Woodline Partners’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.69M | Sell |
1,200,290
-409,157
| -25% | -$2.62M | 0.04% | 479 |
|
|
2025
Q1 | $5.7M | Buy |
+1,609,447
| New | +$5.7M | 0.04% | 474 |
|
|
2024
Q3 | – | Sell |
-523,772
| Closed | -$995K | – | 597 |
|
|
2024
Q2 | $995K | Hold |
523,772
| – | – | 0.01% | 460 |
|
|
2024
Q1 | $1.49M | Buy |
523,772
+52,971
| +11% | +$150K | 0.01% | 441 |
|
|
2023
Q4 | $6.93M | Sell |
470,801
-428,499
| -48% | -$6.31M | 0.08% | 270 |
|
|
2023
Q3 | $16.5M | Hold |
899,300
| – | – | 0.19% | 156 |
|
|
2023
Q2 | $19.4M | Buy |
899,300
+465,100
| +107% | +$10M | 0.23% | 132 |
|
|
2023
Q1 | $12.7M | Sell |
434,200
-74,153
| -15% | -$2.18M | 0.17% | 169 |
|
|
2022
Q4 | $18.8M | Sell |
508,353
-512,031
| -50% | -$18.9M | 0.25% | 117 |
|
|
2022
Q3 | $28.7M | Buy |
1,020,384
+630,155
| +161% | +$17.7M | 0.4% | 65 |
|
|
2022
Q2 | $7.52M | Hold |
390,229
| – | – | 0.12% | 206 |
|
|
2022
Q1 | $5.01M | Buy |
+390,229
| New | +$5.01M | 0.08% | 243 |
|